Evaluating effect of intravenous midazolam on duration of spinal anesthesia
Phase 2
- Conditions
- Spinal anesthetics causing adverse effects in therapeutic useSpinal Anesthesia.E938.7
- Registration Number
- IRCT2014090716415N5
- Lead Sponsor
- Deputy of Research and technology of Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
20 to 60 years old; class American Society of Anesthesiologists (ASA) I or II; no contraindication for midazolam; no benzodiazepine medication before surgery; no history of alcohol or other substance abuse
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of sensory and motor block. Timepoint: Every 2-5 minutes. Method of measurement: Pinprick testing.
- Secondary Outcome Measures
Name Time Method Sedation Score. Timepoint: Every 5 minutes. Method of measurement: Ramsy Sedation Score.